CPHI 2023: Interview from Dr. Sylke Hassel, CEO
Published on November 21, 2023
Last month, Axplora participated in CPHI Worldwide, the unmissable annual event for global players in the pharmaceutical industry.
Let’s get back to this successful CPHI Barcelona 2023 edition in video with an exclusive interview from Dr. Sylke Hassel, led by Life Sciences Knowledge Hub, to discuss the key achievements, forces and breaking news of Axplora:
- Axplora’s broad and strong network of sites, with a global footprint both in Europe and India to answer all customers’ needs and serve patients worldwide.
- The appointment of Dr. Stephan Haitz as Novasep CDMO BU President, and Dr. Pere Paton as Chief Operations Officer, to reinforce Axplora’s position as a leader in the CDMO market.
- The introduction of the newly formed Scientific Advisory Board (SAB): five industry leaders in API development and manufacturing expertise such as Flow chemistry, Electrochemistry, Steroids, Biotechnology and Antibody Drug Conjugates (ADCs).
A year after the merger between Farmabios, Novasep and PharmaZell under the single brand Axplora, CPHI was the unique opportunity to look back over our first few months as a group. A wonderful anniversary for the brand and the teams working hard behind, with promising meetings and fruitful discussions. A great outlook for the future!